May 3, 20230CommentsRx For SuccessThis company’s earnings continue to beat expectations yet the valuation of its stock implies only modest profit growth and still holds upside. by Italo Mendonca
January 11, 20230CommentsFocus List Outperformers with Further Upside – Part 2The rise in healthcare spending and this company's market share leadership position it for continued FCF growth. by Matt Shuler, Investment Analyst II
April 20, 20220CommentsHCA Healthcare (HCA) – 7 reportsSee all our reports on HCA Healthcare. by Kyle Guske II, Senior Investment Analyst, MBA
January 12, 20220CommentsFocus List Outperformer We Still Like – Part 2This report looks at a Focus List Long stock that outperformed in 2021 and is positioned to outperform again in 2022. Part 2. by Matt Shuler, Investment Analyst II
July 28, 20210Comments3 Long Ideas That Remain Attractive Post 2Q21 EarningsAfter 2Q21 earnings, we still love these three Long Ideas that have excellent opportunities for profit growth and attractive risk/reward. by Matt Shuler, Investment Analyst II
December 9, 20200Comments“See Through the Dip” Stocks Significantly Outperform S&P 500Focus on these industry leaders positioned to gain market share from the firms that are forced to fold. by Matt Shuler, Investment Analyst II
June 22, 20200CommentsThis Healthcare Provider Is Ready for the FutureCOVID-19 has disrupted industries all across the globe, perhaps none more than the Healthcare industry. We think there’s great value in this industry leader. by Matt Shuler, Investment Analyst II
December 12, 20180CommentsThree Safe Stocks for a Bear MarketThese companies provide a margin of safety during downturns and can still deliver strong performance in a bull market. by Kyle Guske II, Senior Investment Analyst, MBA